vs
Side-by-side financial comparison of BYLINE BANCORP, INC. (BY) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $112.4M, roughly 1.3× BYLINE BANCORP, INC.). BYLINE BANCORP, INC. runs the higher net margin — 33.4% vs 7.8%, a 25.6% gap on every dollar of revenue. On growth, BYLINE BANCORP, INC. posted the faster year-over-year revenue change (9.0% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 6.4%).
Byline Bank is a bank headquartered in Chicago, Illinois, United States. It is the primary subsidiary of Byline Bancorp, Inc., a bank holding company, and the 4th largest SBA 7(a) lender.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
BY vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $112.4M | $151.7M |
| Net Profit | $37.6M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | — | 20.4% |
| Net Margin | 33.4% | 7.8% |
| Revenue YoY | 9.0% | -41.1% |
| Net Profit YoY | 33.0% | -80.8% |
| EPS (diluted) | $0.83 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $112.4M | — | ||
| Q4 25 | $117.0M | $151.7M | ||
| Q3 25 | $115.7M | $267.8M | ||
| Q2 25 | $110.5M | $244.0M | ||
| Q1 25 | $103.1M | $211.8M | ||
| Q4 24 | $104.7M | $257.6M | ||
| Q3 24 | $101.8M | $78.8M | ||
| Q2 24 | $99.4M | $76.1M |
| Q1 26 | $37.6M | — | ||
| Q4 25 | $34.5M | $11.8M | ||
| Q3 25 | $37.2M | $55.4M | ||
| Q2 25 | $30.1M | $-17.7M | ||
| Q1 25 | $28.2M | $21.2M | ||
| Q4 24 | $30.3M | $61.6M | ||
| Q3 24 | $30.3M | $-8.8M | ||
| Q2 24 | $29.7M | $-364.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% |
| Q1 26 | — | — | ||
| Q4 25 | 40.1% | 20.4% | ||
| Q3 25 | 43.1% | 48.7% | ||
| Q2 25 | 35.2% | 13.8% | ||
| Q1 25 | 36.4% | 38.1% | ||
| Q4 24 | 38.6% | 44.4% | ||
| Q3 24 | 39.3% | 12.3% | ||
| Q2 24 | 40.4% | 7.0% |
| Q1 26 | 33.4% | — | ||
| Q4 25 | 34.1% | 7.8% | ||
| Q3 25 | 32.1% | 20.7% | ||
| Q2 25 | 27.2% | -7.3% | ||
| Q1 25 | 27.4% | 10.0% | ||
| Q4 24 | 34.3% | 23.9% | ||
| Q3 24 | 29.8% | -11.2% | ||
| Q2 24 | 29.9% | -0.5% |
| Q1 26 | $0.83 | — | ||
| Q4 25 | $0.77 | $2.34 | ||
| Q3 25 | $0.82 | $7.76 | ||
| Q2 25 | $0.66 | $-2.95 | ||
| Q1 25 | $0.64 | $3.33 | ||
| Q4 24 | $0.68 | $11.56 | ||
| Q3 24 | $0.69 | $-1.72 | ||
| Q2 24 | $0.68 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $198.4M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $329.4M |
| Total Assets | $9.9B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $198.4M | — | ||
| Q4 25 | $149.1M | $185.6M | ||
| Q3 25 | $259.0M | $166.0M | ||
| Q2 25 | $218.3M | $96.7M | ||
| Q1 25 | $421.3M | $84.7M | ||
| Q4 24 | $563.1M | $40.6M | ||
| Q3 24 | $452.6M | $46.9M | ||
| Q2 24 | $730.5M | $40.8M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $329.4M | ||
| Q3 25 | $1.2B | $317.2M | ||
| Q2 25 | $1.2B | $235.3M | ||
| Q1 25 | $1.1B | $176.9M | ||
| Q4 24 | $1.1B | $132.4M | ||
| Q3 24 | $1.1B | $60.4M | ||
| Q2 24 | $1.0B | $62.7M |
| Q1 26 | $9.9B | — | ||
| Q4 25 | $9.7B | $918.5M | ||
| Q3 25 | $9.8B | $964.5M | ||
| Q2 25 | $9.7B | $841.0M | ||
| Q1 25 | $9.6B | $761.9M | ||
| Q4 24 | $9.5B | $655.3M | ||
| Q3 24 | $9.4B | $438.5M | ||
| Q2 24 | $9.6B | $422.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $140.3M | $70.4M | ||
| Q3 25 | $38.3M | $99.5M | ||
| Q2 25 | $16.3M | $27.3M | ||
| Q1 25 | $27.1M | $51.0M | ||
| Q4 24 | $175.2M | $54.0K | ||
| Q3 24 | $19.8M | $6.8M | ||
| Q2 24 | $40.1M | $13.3M |
| Q1 26 | — | — | ||
| Q4 25 | $136.3M | $69.0M | ||
| Q3 25 | $38.0M | $99.2M | ||
| Q2 25 | $15.2M | $26.5M | ||
| Q1 25 | $25.0M | $50.9M | ||
| Q4 24 | $171.2M | $-341.0K | ||
| Q3 24 | $19.1M | $6.2M | ||
| Q2 24 | $39.4M | $12.7M |
| Q1 26 | — | — | ||
| Q4 25 | 116.5% | 45.5% | ||
| Q3 25 | 32.8% | 37.0% | ||
| Q2 25 | 13.7% | 10.9% | ||
| Q1 25 | 24.3% | 24.0% | ||
| Q4 24 | 163.5% | -0.1% | ||
| Q3 24 | 18.8% | 7.8% | ||
| Q2 24 | 39.7% | 16.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 0.9% | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 1.0% | 0.3% | ||
| Q1 25 | 2.0% | 0.0% | ||
| Q4 24 | 3.8% | 0.2% | ||
| Q3 24 | 0.6% | 0.8% | ||
| Q2 24 | 0.7% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.06× | 5.95× | ||
| Q3 25 | 1.03× | 1.80× | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.96× | 2.40× | ||
| Q4 24 | 5.78× | 0.00× | ||
| Q3 24 | 0.65× | — | ||
| Q2 24 | 1.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BY
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
